Rybrevant (amivantamab-vmjw) is a prescription biologic drug that’s used to treat non-small cell lung cancer (NSCLC). Rybrevant comes as a solution that’s given as an infusion into a vein ...
Hosted on MSN2mon
J&J says its lung cancer drug combination keeps people alive longerJohnson & Johnson said a combination of its lung cancer drugs Rybrevant and Lazcluze kept people alive for at least a year longer than AstraZeneca's Tagrisso in a clinical trial. J&J is trying to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback